| 2026 | Antiparasitic agents in oncology: Innovative mechanisms, emerging evidence and clinical potential in cancer treatment | Raed M Al-Zoubi | 42217373 | https://pubmed.ncbi.nlm.nih.gov/42217373/ | 0 |
| 2026 | Repurposing mebendazole to reprogram oncogenic and tumor-suppressor networks: Multi-cancer insights from ENOX2, MMP2, RASSF1A, WFDC10A and METTL7A | Rasha Shaker Aqel | PMC13020803 | https://pmc.ncbi.nlm.nih.gov/articles/PMC13020803/ | 0 |
| 2025 | The therapeutic potential of repurposed mebendazole, alone and in synergistic combination with ONC201, in the treatment of diffuse midline glioma | Serena Gentile | PMC12256405 | https://pmc.ncbi.nlm.nih.gov/articles/PMC12256405/ | 0 |
| 2025 | Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors | Paul Phan | PMC12741831 | https://pmc.ncbi.nlm.nih.gov/articles/PMC12741831/ | 0 |
| 2025 | Disruption of epidermal growth factor receptor signaling and cytoskeletal dynamics by mebendazole and gefitinib synergistically impairs paracrine cytokine signaling in non-small cell lung cancer and triple-negative breast cancer Cell lines | Mohamed El-Tanani | PMC12707669 | https://pmc.ncbi.nlm.nih.gov/articles/PMC12707669/ | 0 |
| 2024 | Mebendazole induces apoptosis and inhibits migration via the reactive oxygen species-mediated STAT3 signaling downregulation in non-small cell lung cancer | Zhipan Liang | PMC10944755 | https://pmc.ncbi.nlm.nih.gov/articles/PMC10944755/ | 0 |
| 2024 | In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning | Amin Aliabadi | 37837472 | https://pubmed.ncbi.nlm.nih.gov/37837472/ | 0 |
| 2023 | Mebendazole Treatment Disrupts the Transcriptional Activity of Hypoxia-Inducible Factors 1 and 2 in Breast Cancer Cells | Natalie S Joe | PMC9954103 | https://pmc.ncbi.nlm.nih.gov/articles/PMC9954103/ | 0 |
| 2022 | Extensive improvement of oral bioavailability of mebendazole, a brick dust, by polymer-containing SNEDDS preparation: Disruption of high crystallinity by utilizing its counter ion | Yusuke Sumimoto | 35134511 | https://pubmed.ncbi.nlm.nih.gov/35134511/ | 0 |
| 2022 | HPMA Copolymer Mebendazole Conjugate Allows Systemic Administration and Possesses Antitumour Activity In Vivo | Martin Studenovský | PMC9229042 | https://pmc.ncbi.nlm.nih.gov/articles/PMC9229042/ | 0 |
| 2022 | The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole against Colorectal Cancer | Bo Kang | PMC9737525 | https://pmc.ncbi.nlm.nih.gov/articles/PMC9737525/ | 0 |
| 2022 | Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer | Sahar K Hegazy | 35385794 | https://pubmed.ncbi.nlm.nih.gov/35385794/ | 0 |
| 2022 | Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness | Natalie S Joe | PMC9798635 | https://pmc.ncbi.nlm.nih.gov/articles/PMC9798635/ | 0 |
| 2022 | Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer | Suganthapriya Elayapillai | PMC8820236 | https://pmc.ncbi.nlm.nih.gov/articles/PMC8820236/ | 0 |
| 2021 | Treatment of breast and colon cancer cell lines with anti-helmintic benzimidazoles mebendazole or albendazole results in selective apoptotic cell death | Jakeb S S M Petersen | PMC11802096 | https://pmc.ncbi.nlm.nih.gov/articles/PMC11802096/ | 0 |
| 2020 | The Antihelminthic Drug, Mebendazole, Induces Apoptosis in Adult T-Cell Leukemia/Lymphoma Cancer Cells: In-Vitro Trial | Amirhosein Maali | PMC7876428 | https://pmc.ncbi.nlm.nih.gov/articles/PMC7876428/ | 0 |
| 2020 | Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer | Le Zhang | PMC6457649 | https://pmc.ncbi.nlm.nih.gov/articles/PMC6457649/ | 0 |
| 2019 | Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature | Andrea Emanuele Guerini | PMC6769799 | https://pmc.ncbi.nlm.nih.gov/articles/PMC6769799/ | 0 |
| 2019 | Mebendazole induces apoptosis via C-MYC inactivation in malignant ascites cell line (AGP01) | Laine Celestino Pinto | 31207347 | https://pubmed.ncbi.nlm.nih.gov/31207347/ | 0 |
| 2019 | Autophagy Is a Potential Target for Enhancing the Anti-Angiogenic Effect of Mebendazole in Endothelial Cells | So Jung Sung | PMC6319545 | https://pmc.ncbi.nlm.nih.gov/articles/PMC6319545/ | 0 |
| 2018 | Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma | Christine G Skibinski | PMC6387633 | https://pmc.ncbi.nlm.nih.gov/articles/PMC6387633/ | 0 |
| 2017 | Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors | Michelle De Witt | PMC5403762 | https://pmc.ncbi.nlm.nih.gov/articles/PMC5403762/ | 0 |
| 2017 | Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC) | Fugui Zhang | PMC5355070 | https://pmc.ncbi.nlm.nih.gov/articles/PMC5355070/ | 0 |
| 2017 | The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma | Cynthia M Simbulan-Rosenthal | PMC5355037 | https://pmc.ncbi.nlm.nih.gov/articles/PMC5355037/ | 0 |
| 2017 | Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism | Daniel Markowitz | PMC5703169 | https://pmc.ncbi.nlm.nih.gov/articles/PMC5703169/ | 0 |
| 2016 | Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model | Tara Williamson | PMC5356574 | https://pmc.ncbi.nlm.nih.gov/articles/PMC5356574/ | 0 |
| 2016 | Repurposing the antihelmintic mebendazole as a hedgehog inhibitor | Andrew R Larsen | PMC4297232 | https://pmc.ncbi.nlm.nih.gov/articles/PMC4297232/ | 0 |
| 2011 | Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme | Ren-Yuan Bai | PMC3158014 | https://pmc.ncbi.nlm.nih.gov/articles/PMC3158014/ | 0 |
| 2008 | Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells | Nicole Doudican | 18667591 | https://pubmed.ncbi.nlm.nih.gov/18667591/ | 0 |
| 2002 | Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo | Tapas Mukhopadhyay | 12231542 | https://pubmed.ncbi.nlm.nih.gov/12231542/ | 0 |
| 2002 | The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells | Ji-ichiro Sasaki | 12479701 | https://pubmed.ncbi.nlm.nih.gov/12479701/ | 0 |